Roberto Giacomelli

Roberto Giacomelli's AcademicInfluence.com Rankings

Roberto Giacomelli

Computer Science

#9791

World Rank

#10272

Historical Rank

Machine Learning

#4378

World Rank

#4428

Historical Rank

Artificial Intelligence

#4730

World Rank

#4793

Historical Rank

Database

#6746

World Rank

#6984

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Roberto Giacomelli's Degrees

PhD Computer Science University of Milan
Masters Computer Science University of Milan
Bachelors Computer Science University of Milan

Similar Degrees You Can Earn

Why Is Roberto Giacomelli Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Roberto Giacomelli's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond (2004) (638)
Electroweak measurements in electron positron collisions at W-boson-pair energies at LEP (2013) (581)
European multicentre study to define disease activity criteria for systemic sclerosis.* II. Identification of disease activity variables and development of preliminary activity indexes (2001) (320)
Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers (2002) (281)
Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects? (2020) (223)
A comprehensive review on adult onset Still's disease. (2018) (203)
The OPAL Collaboration (2016) (177)
Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation? (2011) (172)
Vascular complications of scleroderma. (2007) (155)
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry. (2012) (155)
Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study. (2007) (147)
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study (2013) (139)
Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis. (2007) (138)
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. (2014) (135)
Infliximab in spondyloarthropathy associated with Crohn’s disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations (2004) (134)
The Role of IL-1β in the Bone Loss during Rheumatic Diseases (2015) (127)
Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium (2016) (125)
Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis (2000) (124)
Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers (2016) (116)
How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project). (2018) (115)
European multicentre study to define disease activity criteria for systemic sclerosis.* I. Clinical and epidemiological features of 290 patients from 19 centres (2001) (114)
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population‐based multicentre cohort study (2015) (109)
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unm (2017) (107)
Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres (2011) (105)
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis (2009) (99)
Methotrexate: an old new drug in autoimmune disease (2014) (98)
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)‐1β via the nucleotide‐binding domain and leucine‐rich repeat containing family pyrin 3(NLRP3)‐inflammasome activation: a possible implication for therapeutic decision in (2015) (98)
Angiogenic cytokines and growth factors in systemic sclerosis. (2011) (97)
Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets (2017) (95)
Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study (2014) (94)
EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells (2008) (94)
A search for lepton flavour violating Z0 decays (1995) (92)
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution. (2015) (89)
Immunomodulation in psoriatic arthritis: focus on cellular and molecular pathways. (2013) (88)
Search for anomalous production of di-lepton events with missing transverse momentum in e+e- collisions at √S = 161 and 172 GeV (1997) (88)
Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot study. (2001) (87)
A comparison of b and uds quark jets to gluon jets (1995) (87)
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients (2016) (84)
Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion. (2008) (83)
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study (2017) (82)
High Levels of Peripheral Blood NK Cells in Women Suffering from Recurrent Spontaneous Abortion are Reverted from High‐Dose Intravenous Immunoglobulins (2006) (82)
Tocilizumab for the treatment of adult-onset Still’s disease: results from a case series (2013) (81)
Search for the minimal standard model Higgs boson (1991) (80)
Anti‐thyroid Antibodies and Antiphospholipid Syndrome: Evidence of Reduced Fecundity and of Poor Pregnancy Outcome in Recurrent Spontaneous Aborters (2004) (79)
Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial (2019) (78)
QCD studies with e+e− annihilation data at 130 and 136 GeV (1996) (78)
Interleukin‐36α axis is modulated in patients with primary Sjögren's syndrome (2015) (77)
Soluble interleukin‐2 receptor, interleukin‐2 and interleukin‐4 in sera and supernatants from patients with progressive systemic sclerosis (1990) (77)
Interstitial lung disease in systemic sclerosis: current and future treatment (2017) (76)
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis. (2019) (75)
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren’s syndrome (2015) (73)
The MACRO detector at Gran Sasso (2002) (73)
Cytokine storm syndrome in severe COVID-19 (2020) (72)
The OPAL silicon-tungsten calorimeter front end electronics (1994) (72)
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm (2020) (71)
Interleukin‐9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis (2016) (71)
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. (2020) (70)
Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI). (2013) (70)
Quality of life and unmet needs in patients with inflammatory arthropathies: results from the multicentre, observational RAPSODIA study. (2015) (69)
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjögren׳s syndrome? Association between clinical, histopathological, and molecular features: a retrospective study. (2014) (69)
A study of differences between quark and gluon jets using vertex tagging of quark jets (1993) (68)
GM‐CSF and Pregnancy: Evidence of Significantly Reduced Blood Concentrations in Unexplained Recurrent Abortion Efficiently Reverted by Intravenous Immunoglobulin Treatment (2003) (68)
Measurement of the production rates of charged hadrons ine+e−-annihilation at theZ0 (1994) (68)
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications. (2006) (68)
T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives (2015) (65)
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist (2015) (64)
Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms. (2014) (63)
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine (2013) (62)
Circulating Vδ1 + T cells are activated and accumulate in the skin of systemic sclerosis patients (1998) (62)
Circulating levels of soluble CD30 are increased in patients with systemic sclerosis (SSc) and correlate with serological and clinical features of the disease (1997) (62)
Computed Tomography and MR Imaging in Rheumatoid Arthritis. (2017) (61)
High levels of NK cells in the peripheral blood of patients affected with anti-phospholipid syndrome and recurrent spontaneous abortion: a potential new hypothesis. (2007) (61)
Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects (2006) (60)
CD4(-)CD8(-) T-cells in primary Sjögren's syndrome: association with the extent of glandular involvement. (2014) (60)
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders. (2018) (60)
Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren’s syndrome with ectopic germinal centres and MALT lymphoma (2020) (60)
Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort (2018) (60)
Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases. (2019) (59)
QCD studies using a cone-based jet finding algorithm fore+e− collisons at LEP (1994) (58)
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular‐based therapy (2013) (58)
A determination ofαs( $$M_{Z^0 } $$ ) at LEP using resummed QCD calculations (1993) (58)
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers. (2017) (58)
Lymphoma and Lymphomagenesis in Primary Sjögren’s Syndrome (2018) (58)
Precision luminosity for Z $^0$ lineshape measurements with a silicon-tungsten calorimeter (2000) (57)
Surface Expression of Fractalkine Receptor (CX3CR1) on CD4+/CD28− T Cells in RA Patients and Correlation with Atherosclerotic Damage (2007) (57)
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study (2003) (57)
Rheumatic manifestations of COVID-19: a systematic review and meta-analysis (2020) (55)
Increase of circulating γ/δ T lymphocytes in the peripheral blood of patients affected by active inflammatory bowel disease (1994) (55)
CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment. (2012) (55)
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy. (2013) (55)
Measurement of single photon production in e+e− collisions near the Z0 resonance (1995) (55)
Magnetic monopole search at high altitude with the SLIM experiment (2008) (54)
Results of the search for strange quark matter and Q-balls with the SLIM experiment (2008) (54)
Cellular players in angiogenesis during the course of systemic sclerosis. (2011) (54)
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups (2021) (54)
Polyclonal B lymphocyte activation in progressive systemic sclerosis. (1989) (53)
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study (2015) (53)
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features (2014) (52)
Bulk etch rate measurements and calibrations of plastic nuclear track detectors (2006) (51)
Measurement of the time dependence of B0d↔B0d mixing using a jet charge technique (1994) (51)
Macrophage activation syndrome in Still’s disease: analysis of clinical characteristics and survival in paediatric and adult patients (2017) (51)
Observations of π-B charge-flavor correlations and resonant Bπ and BK production (1995) (49)
T lymphocytes in the synovial fluid of patients with active rheumatoid arthritis display CD134-OX40 surface antigen. (2001) (48)
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. (2011) (47)
Interleukin‐9 and T helper type 9 cells in rheumatic diseases (2016) (47)
A model independent measurement of quark and gluon jet properties and differences (1995) (47)
Vitamin D and systemic lupus erythematosus - The hype and the hope. (2017) (47)
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. (2015) (47)
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study (2017) (46)
Association of a Functional Polymorphism in the Matrix Metalloproteinase-12 Promoter Region with Systemic Sclerosis in an Italian Population (2010) (46)
Interleukin (IL)‐22 receptor 1 is over‐expressed in primary Sjogren's syndrome and Sjögren‐associated non‐Hodgkin lymphomas and is regulated by IL‐18 (2015) (46)
Measurement of f(c→D∗+X), f(b→D∗+X) and Γcc¯/Γhad using D∗± mesons (1997) (46)
The Italian version of the Family Assessment Device (1998) (45)
Measurement of the mass of the Z boson and the energy calibration of LEP (1993) (45)
Non organ based laboratory markers in systemic sclerosis. (2003) (45)
Circulating γ/δ T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization (2001) (44)
Measurements of $B^{0}-\overline{B}^{0}$ Mixing, $\Gamma(Z^{0} \to b\overline{b}) / \Gamma (Z^{0} \to$ Hadrons) and Semileptonic Branching Ratios for $b$-Flavoured Hadrons in Hadronic $Z^{0}$ Decays (1993) (44)
Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome. (2019) (44)
Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren's syndrome. (2014) (44)
Risk factors for Sjögren's syndrome: a case-control study. (2007) (44)
Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey (2021) (43)
Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1. (1996) (42)
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? (2016) (42)
Serologic Profile and Mortality Rates of Scleroderma Renal Crisis in Italy (2009) (40)
Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma) (2001) (39)
Interleukin (IL)‐9/IL‐9R axis drives γδ T cells activation in psoriatic arthritis patients (2016) (39)
Myositis in primary Sjögren's syndrome: data from a multicentre cohort. (2015) (39)
Increased Cardiovascular Events and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients: 1 Year Prospective Single Centre Study (2017) (38)
Complement System and Rheumatoid Arthritis: Relationships with Autoantibodies, Serological, Clinical Features, and Anti-TNF Treatment (2011) (38)
Unmasking the pathogenic role of IL-17 axis in primary Sjögren's syndrome: a new era for therapeutic targeting? (2014) (37)
Perivascular Cells in Diffuse Cutaneous Systemic Sclerosis Overexpress Activated ADAM12 and Are Involved in Myofibroblast Transdifferentiation and Development of Fibrosis (2016) (37)
Interleukin (IL)‐17‐producing pathogenic T lymphocytes co‐express CD20 and are depleted by rituximab in primary Sjögren's syndrome: a pilot study (2016) (37)
A measurement of the production of D*± mesons on the Z0 resonance (1995) (37)
Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients. (2019) (37)
H‐ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome (2018) (37)
Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome (2012) (36)
Cryoglobulinemia in Sjögren Syndrome: A Disease Subset that Links Higher Systemic Disease Activity, Autoimmunity, and Local B Cell Proliferation in Mucosa-associated Lymphoid Tissue (2017) (36)
A study of B meson oscillations using hadronic Z(0) decays containing leptons (1997) (36)
Precise determination of the Z resonance parameters at LEP: "Zedometry" (2001) (36)
Biologic drugs in adult onset Still’s disease: a systematic review and meta-analysis of observational studies (2017) (36)
Search for "anomalies" from neutrino and anti-neutrino oscillations at Delta_m^2 ~ 1eV^2 with muon spectrometers and large LAr-TPC imaging detectors (2012) (36)
Evidence for chain-like production of strange baryon pairs in jets (1993) (35)
Production of fermion-pair events in e(+)e(-) collisions at 161 GeV centre-of-mass energy (1997) (35)
Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis (2015) (35)
H‐ferritin and CD68+/H‐ferritin+ monocytes/macrophages are increased in the skin of adult‐onset Still's disease patients and correlate with the multi‐visceral involvement of the disease (2016) (35)
Anti-hnRNP and other autoantibodies in systemic sclerosis with joint involvement. (2009) (35)
Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis (2018) (34)
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? (2020) (34)
Phenotypical and Functional Characteristics of in Vitro-Expanded Adipose-Derived Mesenchymal Stromal Cells from Patients with Systematic Sclerosis (2017) (33)
Measurement of $$\Gamma ({\rm Z}^0 \to b\bar b)/\Gamma ({\rm Z}^0 \to hadrons)$$ using leptons (1993) (33)
The −670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis (2008) (33)
Clinical, Epidemiological, and Histopathological Features of Respiratory Involvement in Rheumatoid Arthritis (2017) (33)
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? (2015) (33)
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis (2017) (33)
Pathogenesis of adult onset still’s disease: current understanding and new insights (2018) (33)
Proinflammatory CX3CR1+CD59+Tumor Necrosis Factor–Like Molecule 1A+Interleukin‐23+ Monocytes Are Expanded in Patients With Ankylosing Spondylitis and Modulate Innate Lymphoid Cell 3 Immune Functions (2018) (33)
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? (2017) (32)
A study of b quark fragmentation into B0 and B+ mesons at LEP (1995) (32)
EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19 (2021) (32)
Circulating Vdelta1+ T cells are activated and accumulate in the skin of systemic sclerosis patients. (1998) (32)
Safety and efficacy of intra-articular anti-tumor necrosis factor α agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare (2016) (32)
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence–radiological differences (2020) (32)
Strange baryon production in hadronic Z0 decays (1997) (32)
Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature (2015) (31)
Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis. (2020) (31)
Soluble CD30 in early rheumatoid arthritis as a predictor of good response to second-line therapy. (1999) (31)
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes (2019) (31)
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations (2020) (30)
A study of charm hadron production in $$Z^0 \to c\bar c$$ and $$Z^0 \to b\bar b$$ decays at LEPdecays at LEP (1996) (30)
Natural killer cell frequency and function in patients with monoclonal gammopathies. (1992) (30)
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis (2008) (30)
Search for chargino and neutralino production using the OPAL detector at S=130−136 GeV at LEP (1996) (29)
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study (2019) (29)
Interleukin‐9 over‐expression and T helper 9 polarization in systemic sclerosis patients (2017) (28)
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? (2021) (27)
Search for scalar top and scalar bottom quarks at √s = 183 GeV at LEP (1998) (27)
Test of QCD analytic predictions for the multiplicity ratio between gluon and quark jets (1996) (27)
The Emerging Role of IL-1 Inhibition in Patients Affected by Rheumatoid Arthritis and Diabetes. (2018) (27)
Topological search for the production of neutralinos and scalar particles (1996) (27)
Long-Term Retention Rate of Anakinra in Adult Onset Still’s Disease and Predictive Factors for Treatment Response (2019) (27)
Measurement of the mass of the W boson in $e^+ e^-$ collisions at $\sqrt{s}$ = 161 GeV (1996) (27)
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis (2014) (26)
Post-Translational Modifications of Proteins: Novel Insights in the Autoimmune Response in Rheumatoid Arthritis (2019) (26)
Parenchymal lung disease in adult onset Still’s disease: an emergent marker of disease severity—characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients (2020) (26)
A measurement of charged particle multiplicity in Z0 → cc̄ and Z0 → bb̄ events (1995) (26)
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy (2018) (26)
Investigation of CP violation in B0 → J/ψKS0 decays at LEP (1998) (26)
Increase of circulating gamma/delta T lymphocytes in the peripheral blood of patients affected by active inflammatory bowel disease. (1994) (26)
Interferon gamma-inducible protein 16 in primary Sjögren’s syndrome: a novel player in disease pathogenesis? (2015) (25)
Measurement of cross-sections and asymmetries in e+e− collisions at 130–140 GeV centre-of-mass energy (1996) (25)
Search for the standard model Higgs boson in e+e- collisions at v = 161-172 GeV (1997) (25)
Multiplicity and transverse momentum correlations in multihadronic final states in e+e− interactions at √s = 91.2 GeV (1994) (25)
Analysis of hadronic final states and the photon structure function F-2(gamma) in deep inelastic electron-photon scattering at LEP (1997) (25)
Improved measurements of the neutral current from hadron and lepton production at LEP (1994) (25)
The kaleidoscope of neurological manifestations in primary Sjögren's syndrome. (2019) (25)
The CD68+/H‐ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H‐ferritin in the same tissue: correlation with disease severity and implication for pathogenesis (2016) (25)
Rituximab in primary Sjögren's syndrome: a ten-year journey (2014) (25)
The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjögren's syndrome (2014) (24)
Measurement of the B0 and B+ lifetimes (1993) (24)
Evaluation of motorway pollution in a mountain ecosystem. Pilot project: Susa Valley (Northwest Italy) years 1990–1994 (1996) (24)
Search for heavy charged particles and for particles with anomalous charge in e+e− collisions at LEP (1995) (24)
The production of neutral kaons in Z0 decays and their Bose-Einstein correlations (1995) (24)
The effect of non-TNF-targeted biologics and small molecules on insulin resistance in inflammatory arthritis. (2018) (24)
Search for neutral Higgs bosons in $Z^0$ decays using the OPAL detector at LEP (1997) (24)
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus. (2020) (23)
Studies of charged particle multiplicity inb quark events (1994) (23)
An upper limit on the anomalous magnetic moment of the τ lepton (1998) (23)
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis (2017) (23)
Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still’s disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort (2020) (23)
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis (2017) (23)
Search for anomalous production of high mass photon pairs in e+e− collisions at LEP (1993) (23)
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities (2018) (23)
Improved measurement of the lifetime of the τ lepton (1996) (23)
The treatment of adult-onset Still's disease with anakinra, a recombinant human IL-1 receptor antagonist: a systematic review of literature. (2020) (23)
Inclusive strange vector and tensor meson production in hadronic Z0 decays (1995) (23)
Histopathology of salivary glands. (2018) (23)
Measurement of the multiplicity of charm quark pairs from gluons in hadronic Z0 Decays (1995) (23)
Search for CP violation in Z0 → τ+τ- and an upper limit on the weak dipole moment of the τ lepton (1997) (22)
A search for neutral Higgs bosons in the MSSM and models with two scalar field doublets (1998) (22)
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study (2017) (22)
Multiplicity dependence of Bose-Einstein correlations in hadronic Z0 decays (1996) (22)
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts (2015) (22)
Measurement of the Q2 evolution of the photon structure function F2γ (1997) (21)
Factors influencing the patient evaluation of injection experience with the SmartJect autoinjector in rheumatoid arthritis. (2015) (21)
A study of charm hadron production in Z0 → cc̄ and Z0 → bb̄ decays at LEP (1996) (21)
Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis. (2006) (21)
Measurement of the B(s)0 lifetime (1993) (20)
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease (2019) (20)
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19 (2021) (20)
Determination of the production rate of D*0 mesons and of the ratio V/(V+P) in $$Z^0 \to c\bar c$$ decays (1998) (20)
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. (2015) (20)
Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor (2017) (20)
Measurement of the longitudinal, transverse and asymmetry fragmentation functions at LEP (1995) (20)
Radionuclide concentrations in air and their deposition at Saluggia (Northwest Italy) following the Chernobyl nuclear accident (1990) (19)
Vitamin D increases the production of IL-10 by regulatory T cells in patients with systemic sclerosis. (2019) (19)
Circulating gamma/delta T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization. (2001) (19)
Measurement of the τ lifetime (1979) (19)
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling (2019) (19)
The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn). (2005) (19)
A Study of charm Hadron Production in $Z^{0} \to c\overline{c}$ and $Z^{0} \to b\overline{b}$ Decays at LEP (1996) (19)
Precision measurements of the neutral current from hadron and lepton production at LEP (1993) (19)
Natural killer activity and antibody‐dependent cellular cytotoxicity in progressive systemic sclerosis (1990) (19)
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis (2018) (18)
Combination therapy with cyclosporine and methotrexate in patients with early rheumatoid arthritis soon inhibits TNFalpha production without decreasing TNFalpha mRNA levels. An in vivo and in vitro study. (2002) (18)
Study of Phi(1020), D*+/- and B* spin alignment in hadronic Z(0) decays (1997) (18)
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study (2019) (18)
Measurement of the quark to photon fragmentation function through the inclusive production of prompt photons in hadronic Z(0) decays (1997) (17)
Downregulation of miRNA17–92 cluster marks Vγ9Vδ2 T cells from patients with rheumatoid arthritis (2018) (17)
Search for anomalous production of photonic events with missing energy in e+e- collisions at √s = 130-172 GeV (1998) (17)
The Vessels Contribute to Fibrosis in Systemic Sclerosis. (2019) (17)
Spin alignment of leading K∗(892)0 mesons in hadronic Z0 decays (1997) (17)
Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases (2021) (17)
Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis. (2005) (17)
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension (2020) (17)
Patients’, physicians’, nurses’, and pharmacists’ preferences on the characteristics of biologic agents used in the treatment of rheumatic diseases (2018) (16)
Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF-α Receptor—Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA Network (2020) (16)
Prescribing motivations and patients’ characteristics related to the use of biologic drugs in adult-onset Still’s disease: analysis of a multicentre “real-life” cohort (2019) (16)
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome. (2020) (16)
Measurement of the photon structure functionF2γ in the reactione+e−→e+e−+hadrons at LEP (1994) (16)
The effect of non-TNF-targeted biologics on vascular dysfunction in rheumatoid arthritis: A systematic literature review. (2019) (16)
Variations of neuronal nitric oxide synthase in systemic sclerosis skin. (2006) (16)
Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes. (2005) (16)
Updated measurement of the τ lifetime (1994) (16)
Gamma/delta T cells in placenta and skin: their different functions may support the paradigm of microchimerism in systemic sclerosis. (2004) (16)
Search for chargino and neutralino production in e+e− collisions at (1996) (16)
Interleukin‐25 Axis Is Involved in the Pathogenesis of Human Primary and Experimental Murine Sjögren's Syndrome (2018) (16)
Insecticide-Acaricide Metabolism, Metabolic Fate of p32Labeled Dimethoate on Olive Fruits and Some Toxicological Implications (1962) (16)
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS (2013) (16)
Improved measurements of the B0 and B+ meson lifetimes (1995) (16)
Seasonal variations of 137Cs activities in the Dora Baltea River (Northwest Italy) after the chernobyl accident (1994) (16)
A measurement of the hadronic decay current and the nu(tau)-helicity in tau(-)->pi(-)pi(-)pi(+)nu(tau) (1997) (15)
A first measurement of the Λ and ΛΛ () spin compositions in hadronic Z0 decays (1996) (15)
Multiplicity distributions of gluon and quark jets and tests of QCD analytic predictions (1997) (15)
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment (2020) (15)
An improved measurement of R-b using a double tagging method (1997) (15)
Search for a scalar top quark using the OPAL detector (1994) (15)
Measurements with photonic events in e+e− collisions at centre-of-mass energies of 130–140 GeV (1996) (15)
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study (2019) (14)
Celiac Disease Prevalence Is Increased in Primary Sjögren’s Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study (2019) (14)
Search for unstable heavy and excited leptons in e+e− collisions at ∝s = 170-172 GeV (1997) (14)
Search for charged Higgs bosons using the OPAL detector at LEP (1996) (14)
Measurement of the triple gauge boson coupling αWφ from W+W− production in e+e− collisions at GeV (1997) (14)
Levels and Factors Associated with Resilience in Italian Healthcare Professionals during the COVID-19 Pandemic: A Web-Based Survey (2020) (14)
Ferritin and Severe COVID-19, from Clinical Observations to Pathogenic Implications and Therapeutic Perspectives. (2020) (14)
Inhibition of the Complement System by Glutathione: Molecular Mechanisms and Potential Therapeutic Implications (2011) (14)
The Impact of Fibromyalgia in Spondyloarthritis: From Classification Criteria to Outcome Measures (2018) (14)
CCL 2 , CCL 3 and CCL 5 chemokines in systemic sclerosis : the correlation with SSc clinical features and the effect of prostaglandin E 1 treatment (2006) (14)
Δ++ production in hadronic Z0 decays (1995) (14)
Measurement of the averageb hadron lifetime inZ0 decays (1993) (14)
Pupillocynetic activity of substance P in systemic sclerosis. (2003) (14)
Soluble CD30 in primary Sjögren's syndrome. (1999) (13)
Piascledine modulates the production of VEGF and TIMP‐1 and reduces the invasiveness of rheumatoid arthritis synoviocytes (2006) (13)
A measurement of the average lifetime of b-flavoured baryons (1993) (13)
A study of charm meson production in semileptonic B decays (1995) (13)
A measurement of the QCD colour factor ratiosCA/CF andTF/CF from angular correlations in four-jet events (1995) (13)
Production of P-wave charm and charm-strange mesons in hadronic Z(0) decays (1997) (13)
Measurement of the time dependence of Bd0 ↔ Bd0 mixing using leptons and D∗± mesons (1994) (13)
A measurement of the forward-backward asymmetry of e+e−→bb by applying a jet charge algorithm to lifetime tagged events (1995) (13)
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes (2020) (13)
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies very early cardiac involvement in systemic sclerosis patients of recent onset (2017) (13)
Search for scalar top and scalar bottom quarks at √s = 170-172 GeV in e+e- collisions (1997) (13)
Measurement of the W boson mass and W+W− production and decay properties in e+e− collisions at √s=172 GeV (1998) (13)
Endothelial progenitor cells: Are they displaying a function in autoimmune disorders? (2016) (12)
Measurement of triple gauge boson couplings from W+W- production at √s = 172GeV (1997) (12)
Inclusive jet production in photon-photon collisions at root s(ee)=130 and 136 GeV (1997) (12)
An improved measurement of the BS0 lifetime (1995) (12)
Glucocorticoids in rheumatoid arthritis: the silent companion in the therapeutic strategy (2020) (12)
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis (2021) (12)
The reduction of concomitant glucocorticoids dosage following treatment with IL-1 receptor antagonist in adult onset Still’s disease. A systematic review and meta-analysis of observational studies (2020) (12)
Childhood-onset of primary Sjögren's syndrome: phenotypic characterization at diagnosis of 158 children. (2021) (12)
Σ+, Σ0 and Σ− hyperon production in hadronic Z0 decays (1997) (12)
Hyaluronic acid and platelet-rich plasma, a new therapeutic alternative for scleroderma patients: a prospective open-label study (2019) (12)
AB0051 Monocytes from Patients with Rheumatoid Arthritis and Type 2 Diabetes Mellitus Display an Increased Production of IL-1β Via the NLRP3-Inflammasome Activation. A Possible Implication for Therapeutic Decision in These Patients (2015) (12)
Metabolic Syndrome and psoriatic arthritis: considerations for the clinician (2020) (12)
Stem cell therapies for systemic sclerosis (2015) (12)
Measurement of the τ− → h− π0ντ and τ− → h− ⩾ 2π0ντ branching ratios (1994) (12)
Measurement of the average $b$ baryon lifetime and the product branching ratio f ($b \to Lambda_b$ ) x BR (Lambda($b$) $\to \Lambda \ell^-$ anti-neutrino $X^{)}$ (1996) (12)
Dissecting the clinical heterogeneity of adult-onset Still's disease, results from a multi-dimensional characterisation and stratification. (2021) (12)
A measurement of the forward-backward asymmetry of $$e^ + e^ - \to c\bar c$$ and $$e^ + e^ - \to b\bar b$$ at centre of mass energies on and near theZ0 peak usingD*± mesons (1993) (11)
Measurement of the one-prong hadronic tau branching ratios at LEP (1998) (11)
The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection (2020) (11)
Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE). (2017) (11)
Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis. (2002) (11)
The Pathogenic Role of Interferons in the Hyperinflammatory Response on Adult-Onset Still’s Disease and Macrophage Activation Syndrome: Paving the Way towards New Therapeutic Targets (2021) (11)
Epidemiologic Subsets Drive a Differentiated Clinical and Immunological Presentation of Primary Sjogren Syndrome : Analysis of 9302 Patients from the Big Data International Sjogren Cohort (2017) (11)
Test of the four-fermion contact interaction in e+e− collisions at 130–140 GeV (1996) (11)
Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies. (2020) (11)
Observation of γ production in hadronic Z0 decays (1996) (11)
A measurement of the charm and bottom forward-backward asymmetries using D mesons at LEP (1997) (11)
Measurement of |V(cb)| using B̄0 → D*+l-ν̄ decays (1997) (11)
T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy. (2019) (11)
A study of the electric charge-distributions of quark and gluon jets in hadronic z0 decays (1993) (11)
Cytokine production in patients with monoclonal gammapathies. (1991) (11)
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments. (2021) (10)
A study of muon pair production and evidence for tau pair production in photon-photon collisions at LEP (1993) (10)
Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: the experience of two Italian integrated Dermatology/Rheumatology outpatient clinics (2015) (10)
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study (2020) (10)
Production of f(0)(980), f(2)(1270) and phi(1020) in hadronic Z(0) decay (1998) (10)
A study of B meson oscillations using dilepton events (1995) (10)
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients (2020) (10)
Measurements of the $B^{0}_s$ and $\Lambda^{0}_b$ lifetimes (1997) (10)
The forward-backward asymmetry of $$e^ + e^ - \to b\bar b and e^ + e^ - \to c\bar c$$ using leptons in hadronicZ0 decays (1993) (10)
Search for anomalies in the neutrino sector with muon spectrometers and large LArTPC imaging detectors at CERN (2012) (10)
Rheumatic manifestations of COVID-19: a systematic review and meta-analysis. (2020) (10)
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial. (2021) (10)
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren’s syndrome minor salivary glands (2019) (10)
Measurement of the photon structure function F-2(gamma) at low x (1997) (10)
Transport of 131I and 137Cs from air to cows' milk produced in North-Western Italian farms following the Chernobyl accident (1991) (10)
Studies of strong and electroweak interactions using final state photon emission in hadronicZ0 decays (1993) (10)
Measurements of $$B^0 - \bar B^0 $$ mixing, $${{\Gamma (Z^0 \to b\bar b)} \mathord{\left/ {\vphantom {{\Gamma (Z^0 \to b\bar b)} {\Gamma (Z^0 \to hadrons)}}} \right. \kern-\nulldelimiterspace} {\Gamma (Z^0 \to hadrons)}}$$ and semileptonic branching ratios forb-flavoured hadrons in hadronicZ0 deca (1993) (10)
A precise measurement of the tau polarization and its forward-backward asymmetry at LEP (1996) (10)
Search for scalar top and scalar bottom quarks using the OPAL detector at LEP (1996) (9)
Erratum: Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-α blockers: The GISEA study (Journal of Rheumatology (2007) 34, (1670-1673)) (2007) (9)
Dose adjustments and discontinuation in TNF inhibitors treated patients: when and how. A systematic review of literature. (2018) (9)
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis (2005) (9)
Searching for a good model for systemic sclerosis: the molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis (2016) (9)
Endothelial‐to‐mesenchymal transition in systemic sclerosis (2021) (9)
Targeted synthetic pharmacotherapy for psoriatic arthritis: state of the art (2020) (9)
The role of T helper 17 cell subsets in Sjögren's syndrome: similarities and differences between mouse model and humans (2014) (9)
A measurement of the Bd0 oscillation frequency using leptons and D*± mesons (1996) (9)
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts (2019) (9)
Search for charged scalar leptons using the OPAL detector at s=161 GeV (1997) (9)
Persistence of focal lymphocytic sialadenitis in patients with primary Sjögren's syndrome treated with rituximab: a possible role for glandular BAFF. (2016) (9)
An observational prospective study on predictors of clinical response at six months in patients with active psoriatic arthritis treated with golimumab. (2019) (9)
Definition of fibromyalgia severity: findings from a cross-sectional survey of 2339 Italian patients. (2020) (9)
Measurement of the hadronic decay current in τ−→π−−+vτ (1995) (9)
Microchimerism in Sjögren's syndrome (2002) (9)
Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis (2020) (9)
Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review). (2019) (8)
A measurement of |Vcb| using B̄0 → D*+ℓ-v̄ℓ decays (1997) (8)
Search for unstable neutral and charged heavy leptons in e+e- collisions at √s = 130 and 136 GeV (1996) (8)
Measurement of the tau lepton polarization and its forward-backward asymmetry from Z0 decays (1995) (8)
The Effect of Ketogenic Diet on Inflammatory Arthritis and Cardiovascular Health in Rheumatic Conditions: A Mini Review (2021) (8)
A test ofCP-invariance in Z0→τ+τ− using optimal observables (1995) (8)
Hyperuricemia in Psoriatic Arthritis: Epidemiology, Pathophysiology, and Clinical Implications (2021) (8)
Measurements of the b quark forward-backward asymmetry around the Z0 peak using jet charge and vertex charge (1997) (8)
A measurement of the average bottom hadron lifetime (1997) (8)
Insulin Signaling in Arthritis (2021) (8)
Search for excited leptons in e+e- collisions at ss = 130 and 136 GeV (1996) (8)
Cardiovascular Disease in Primary Sjögren's Syndrome. (2018) (8)
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases (2022) (8)
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study. (2020) (7)
Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data (2020) (7)
Search for neutral Higgs bosons in the minimal supersymmetric extension of the standard model (1994) (7)
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network (2020) (7)
Searches for supersymmetric particles and anomalous four-jet production at root s=130 and 136 GeV at LEP (1997) (7)
The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile (2021) (7)
Development and Implementation of the AIDA International Registry for Patients With Still's Disease (2022) (7)
Hepatitis E infection in a patient with rheumatoid arthritis treated with leflunomide (2019) (7)
A study of four-fermion final states with high multiplicity at LEP (1996) (7)
Correlation between ESSDAI and ClinESSDAI in a real-life cohort of patients with Sjögren's syndrome. (2017) (7)
Search for possible neutrino radiative decays during the 2001 total solar eclipse (2004) (7)
A measurement of the B-s(0) lifetime using reconstructed D-s(-) mesons (1997) (7)
An updated study of B meson oscillations using dilepton events (1997) (7)
Validation of thymic stromal lymphopoietin as a biomarker of primary Sjögren's syndrome and related lymphoproliferation: results in independent cohorts. (2020) (7)
The economic burden of fibromyalgia: A systematic literature review. (2022) (7)
Search for rare hadronic B decays (1994) (7)
Differential expression of tissue kallikrein in the skin of systemic sclerosis. (2005) (7)
The classification criteria for Sjögren syndrome: issues for their improvement from the study of a large Italian cohort of patients (2014) (7)
$J/\psi$ and $\psi '$ Production in Hadronic $Z^{0}$ Decays (1996) (7)
AB0328 What Could We Learn from The Sub-Analysis of A Single Nation Cohort in A Worldwide Study? Lesson from The Results Observed in The Italian Cohort of The GO-MORE Trial (2016) (6)
Search for unstable neutral and charged heavy leptons in e+e− collisions at (1997) (6)
A fast automatic plate changer for the analysis of nuclear emulsions (2013) (6)
Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders (2021) (6)
Photonic events with large missing energy in e+e− collisions at s=161 GeV (1997) (6)
A study of mean sub-jet multiplicities in two- and three-jet hadronicZ0 decays (1994) (6)
Measurements of the inclusive branching ratios of τ-leptons to K0S and charged K∗(892) (1994) (6)
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome (2022) (6)
Test of the exponential decay law at short decay times using $\tau$ leptons (1996) (6)
Polarization and Forward-Backward Asymmetry of Λ Baryons in Hadronic Z 0 Decays The OPAL Collaboration (1997) (6)
Association Between Minor Salivary Gland Biopsy During Sjӧgren’s Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis (2021) (6)
Measurement of {Mathematical expression}using a double tagging method (1995) (6)
Peripheral Nervous System Involvement in Sjögren’s Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren’s Syndrome (2021) (6)
Maladaptive Autophagy in the Pathogenesis of Autoimmune Epithelitis in Sjögren's Syndrome (2021) (6)
Search for the standard model Higgs boson in e+e- collisions at √s = 161 GeV (1997) (6)
A measurement ofΓ (Z0→b $$\Gamma ({\rm Z}^0 \to b\bar b)$$ /Γ(Z0→hadrons) using an impact parameter technique (1993) (6)
Search for massive, unstable photinos that violate R parity (1993) (6)
A test of the flavour independence of the strong interaction for five flavours (1993) (6)
Prevalence and significance of anti-saccharomyces cerevisiae antibodies in primary Sjögren's syndrome. (2018) (6)
Influence of the age at diagnosis in the disease expression of primary Sjögren syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium. (2021) (6)
Safety and efficacy of certolizumab pegol in a real-life cohort of patients with psoriasis and psoriatic arthritis (2019) (5)
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis (2022) (5)
The Need to Target Mucosa‐Associated Lymphoid Tissue for Preventing Lymphoma in Rheumatoid Factor–Positive Patients With Sjögren's Syndrome: Comment on the Article by Nocturne et al (2016) (5)
Search for nuclearites with the SLIM detector (2005) (5)
Measurement of the average b-baryon lifetime and the product branching ratio $f(b \rightarrow \Lambda_{b}) \cdot BR(\Lambda_{b} \rightarrow \Lambda \ell^{-}\overline{\nu}X)$ (1995) (5)
Observation of exclusive decays of B mesons at LEP (1994) (5)
Italian recommendations for influenza and pneumococcal vaccination in adult patients with autoimmune rheumatic diseases. (2020) (5)
Measurement of the leptonic branching ratios of the τ lepton (1995) (5)
The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts: implication of disease-associated and traditional risk factors as emerged by a 16-year retrospective GIRRCS study (2018) (5)
Evidence of drug interaction between cyclosporin A and H2-receptor antagonists (cimetidine, ranitidine and famotidine) in Sprague-Dawley rats. (1989) (5)
THU0198 Patient Evaluations of Autoinjectors for Delivery of Subcutaneous Golimumab for Treatment of Rheumatoid Arthritis (2013) (5)
Significance of anti-La/SSB antibodies in primary Sjögren's syndrome patients with combined positivity for anti-Ro/SSA and salivary gland biopsy. (2020) (5)
Haematopoietic stem cell transplantation in systemic sclerosis: Challenges and perspectives. (2020) (5)
Development and implementation of the AIDA International Registry for patients with Behçet’s disease (2022) (5)
Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome—Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA Network (2021) (5)
Characterization and outcomes of 414 patients with primary SS who developed hematological malignancies. (2022) (5)
Adult-onset Still's disease with elderly onset, results from a multicentre study. (2021) (5)
Search for charged Higgs bosons in $e^{+} e^{-}$ collisions at $S^{(1/2)}$ = 130-GeV - 172-GeV (1998) (5)
Changing the outcome measures, changing the results? The urgent need of a specific disease activity score to adult-onset Still’s disease (2020) (5)
Laboratory Assessment of Patients with Suspected Rheumatic Musculoskeletal Diseases: Challenges and Pitfalls. (2018) (5)
The association between body mass index and fibromyalgia severity: data from a cross-sectional survey of 2339 patients (2021) (5)
AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) (2019) (5)
Measurement of the branching ratio (1996) (5)
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud’s phenomenon: a case–control study (2019) (4)
Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications. (2022) (4)
Multi-photon final states in e+e− collisions at ∝s =130-172 GeV (1997) (4)
47 - Infection and Systemic Sclerosis (2004) (4)
Anakinra effectiveness in refractory polyserositis: an Italian multicenter study. (2021) (4)
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases (2020) (4)
Resistance to Apoptosis in Circulating α / ß and γ / δ T Lymphocytes from Patients with Systemic Sclerosis (2006) (4)
Written and Spoken Language in Latin-Faliscan and Greek-Messapic (1979) (4)
The syndrome of idiopathic CD4+ lymphocytopenia. (1994) (4)
Low-Dose Aspirin as Primary Prophylaxis for Cardiovascular Events in Rheumatoid Arthritis: An Italian Multicentre Retrospective Study (2019) (4)
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still’s disease (2022) (4)
Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry. (2022) (4)
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases (2022) (4)
Comparisons of the properties of final state photons in hadronic Z0 decays with predictions from matrix element calculations (1995) (4)
Use of Rituximab in the Management of Sjögren’s Syndrome (2015) (4)
Advanced diagnostic imaging and intervention in tendon diseases (2020) (4)
Familial scleroderma: Do environmental factors, genes and microchimerism share the same relevance? (2001) (4)
The challenge to interpret conflicting results and the need of a univocal definition for germinal centres in primary Sjögren’s syndrome (2017) (4)
Search for a massive Di-photon resonance at ∝s = 91 – 172 GeV (1997) (4)
Investigation of CP violation in B 0 → J /ψ K 0S decays at LEP The OPAL Collaboration (1998) (3)
Inflammation and Dysmetabolism in Systemic Autoimmune Diseases (2019) (3)
Soluble CD8 antigen in systemic sclerosis. (1990) (3)
Videoconferences in physics (1997) (3)
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 (2022) (3)
Measurement of QED structure functions of the photon using azimuthal correlations at LEP (revised title) (1997) (3)
The LEP Legacy (2005) (3)
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease. (2022) (3)
Determination of an upper limit for the mass of the τ-neutrino at LEP (1995) (3)
Investigation of the string effect using final state photons (1995) (3)
Adipose stromal vascular fraction and regenerative therapy in SSc: response to the article by Magalon et al (2019) (3)
The clinical heterogeneity of adult onset Still's disease may underlie different pathogenic mechanisms. Implications for a personalised therapeutic management of these patients. (2022) (3)
Search for a narrow resonance in Z0 decays into hadrons and isolated photons (1996) (3)
Diagnostic and interventional radiology fundamentals of synovial pathology (2020) (3)
Measurement of the branching fraction of the radiative decay τ− → μ−νμντγ (1996) (3)
Vitamin D increases the production of IL-10 by regulatory T cells in patients with systemic sclerosis. (2020) (3)
Tests of the Standard Model and Constraints on New Physics from Measurements of Fermion-pair Production at 130 { 172 GeV at LEP (1997) (3)
OP0089 Big Data Sjögren Project (Eular-SS Task Force International Network): Characterization at Diagnosis of 5027 Patients with Primary Sjögren Syndrome (2015) (3)
A study of QCD structure constants and a measurement of $$\alpha _s (M_{Z^0 } )$$ at LEP using event shape observables (1995) (3)
Aerobiological survey in L'Aquila (Italy) throughout 1988 to 1990 (1992) (3)
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study: Erratum (2017) (3)
Interplay of anti‐SSA/SSB status and hypertension in determining cardiovascular risk in primary Sjögren’s syndrome (2020) (3)
Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: a report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group (2021) (3)
Addressing the clinical unmet needs in primary Sjögren’s Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts (2022) (3)
Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from Ssc Patients Induces an Anti Angiogenetic Effect, when Co-cultured with Endothelial Cells (2015) (3)
Prevalence and death rate of COVID-19 in systemic autoimmune diseases in the first three pandemic waves. Relationship to disease subgroups and ongoing therapies. (2022) (3)
Childhood-onset of primary Sjogren syndromePhenotypic characterization at diagnosis of 158 children (2020) (3)
Search for an excess in the production of four-jet events from e+e- collisions at √s = 130-184 GeV (1998) (2)
Modulation by ST 789 of in vitro lymphocyte activation and cytokine production. (1992) (2)
New lower limits on the lifetime of heavy neutrino radiative decay (2009) (2)
Results from high-energy e+ e- collisions (1998) (2)
Tailored approach to rheumatoid arthritis treatment with TNF inhibitors: where do we stand? (2018) (2)
FRI0419 Big Data Sjogren Project (Eular-SS Task Force International Network): Systemic Involvement at Diagnosis Evaluated by the Essdai in 3314 Patients with Primary Sjögren Syndrome (2015) (2)
Efficacy and safety of imatinib mesylate in systemic sclerosis. A systematic review and meta-analysis (2020) (2)
Measurement of the semileptonic branching fraction of inclusive b baryon decays to Lambda (1997) (2)
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine (2013) (2)
Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study (2022) (2)
Separation and sequential determination of americium and plutonium in urine samples (1984) (2)
Determination of event shape distributions and αsb from $$Z^0 \to b\bar b$$ events at LEP (1994) (2)
Inclusive jet production in photon-photon collisions at √see = 130 and 136 GeV (1997) (2)
A precise measurement of the tau polarization and its forward-backward asymmetry at LEP (1996) (2)
Measurements of the B 0 s and Λ 0 b Lifetimes The OPAL Collaboration (1991) (2)
Hypoxanthine derivatives in experimental infections (1992) (2)
Isolated “puffy hands” following COVID-19: clue to a long-term capillary leakage syndrome? (2021) (2)
OP0120 Influence of epidemiology and ethnicity on systemic expression of primary sjÖgren syndrome in 9974 patients (2018) (2)
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis (2022) (2)
Impact of smoking habit on adult-onset Still’s disease prognosis, findings from a multicentre observational study (2021) (2)
The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease. (2022) (2)
Measurement of $$\Gamma (Z^0 \to b\bar b)/\Gamma (Z^0 \to hadrons)$$ using impact parameters and leptons (1994) (2)
Association between the MMP-12 gene and systemic sclerosis: role of RS2276109 functional polymorphism in the modulation of skin and pulmonary fibrosis (2010) (2)
Assessment of health-related quality of life in patients with adult onset Still disease: Results from a multicentre cross-sectional study. (2022) (2)
Cyclosporine in ulcerative colitis complications (1992) (2)
Mesenchymal Stem Cell Transplantation in Systemic Sclerosis: Comment on the Article by Maria et al (2016) (2)
Measurement of the average b-baryon lifetime and the product branching ratio $$f(b \to \Lambda _b ) \cdot BR(\Lambda _b \to \Lambda \ell ^ - \bar vX)$$ (1995) (2)
Measurement of triple gauge boson couplings from ${\rm W^+W^-}$ production at $\sqrt s=172$GeV (1998) (2)
Systemic Sjögren presenting without sicca syndrome : characterization of 240 patients according to the new 2017 ACR/EULAR Classification Criteria (2018) (1)
OP0279 A UNIQUE IL-21 SIGNATURE CHARACTERIZES LESIONAL AND CIRCULATING T-FOLLICULAR HELPER CELLS IN SJÖGREN’S SYNDROME PATIENTS WITH ECTOPIC GERMINAL CENTRES AND MALT LYMPHOMA (2019) (1)
Correction to: Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts (2020) (1)
Erratum to “Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren’s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study” [Semin Arthritis Rheum 44 (2014) 314–324] (2015) (1)
THU0268 Prevalence and features of celiac disease in patients with systemic autoimmune diseases: results of a large multicenter study (2017) (1)
Measurement of the tau- ---> h- h+ h- tau-neutrino and tau- ---> h- h+ h- >= 1 pi0 tau-neutrino branching ratios (1995) (1)
THU0341 Correlation between Essdai and Clinessdai in A Real-Life Cohort of Sjögren's Syndrome Patients (2016) (1)
Inosine pranobex in the combination therapy of HIV infection. (1992) (1)
Measurement of the τ−→h−h+h−vτ and τ−→h−h+h−≥1π0vτ branching ratios (1995) (1)
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients. (2021) (1)
THU0681 Baseline ESSDAI/DAS scores in 8061 patients with primary sjÖgren syndrome: characterization of systemic disease (2017) (1)
Microsurgical and Endoscopic Approaches to the Skull Base (2021) (1)
Imbalance of immune functions in progressive systemic sclerosis patients (1988) (1)
Evaluation of the morphological and functional damage to human sperm subjected to freezing at -196 degrees C and to refrigeration at +4 degrees C. (1993) (1)
Response to: ‘Correspondence on ‘Changing the outcome measures, changing the results? The urgent need of a specific disease activity score to adult-onset Still’s disease’’ by Muraviov and Muraviova (2020) (1)
Response to: ‘Correspondence on ‘Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence–radiological differences’ by Ruscitti et al’ by Chen et al (2020) (1)
AB0465 Etanercept therapy in rheumatoid arthritis patients with moderate or severe disease activity (2013) (1)
AB0248 Epidermal growth factor-like domain 7 (EGFL7) in skin of systemic sclerosis (2013) (1)
Upper limit on theντ mass fromτ → 3hντ decays (1996) (1)
THU0634 Comparing preferences of patients with rheumatic diseases, of rheumatologists, nurses and pharmacists toward the treatment of rheumatic diseases with biological agents: results from the cara study (2017) (1)
The NESSiE Concept for Sterile Neutrinos (2013) (1)
Prompt J/$ production in hadronic 2' decays (1996) (1)
[Heterogeneity of epitopes of the CD4 molecule in a female patient with idiopathic pulmonary fibrosis]. (1989) (1)
A measurement of the hadronic decay current and the ντ-helicity in τ- → π- π- π+ ντ (1997) (1)
THU0260 IL-25 Axis Is Activated and Associated with An ILC2 and M2 Inflammatory State in Patients with Primary Sjogren's Syndrome (2016) (1)
Computing at Future Accelerator and Non Accelerator Large Experiments (2002) (1)
Search for “anomalies” from neutrino and anti-neutrino oscillations at Δm ≈ 1eV with muon spectrometers and large LAr–TPC imaging detectors. Technical proposal. (CERN-SPSC-2012-010 and SPSC-P-347) ICARUS Collaboration (2012) (1)
Drug interaction between cyclosporin A and nizatidine in Sprague-Dawley rats. (1990) (1)
Searches for Supersymmetric Particles and Anomalous Four-Jet Production at p s = 130 and 136 GeV at LEP The OPAL Collaboration (1996) (1)
OP0126 LYMPHOMA ARISING AT THE TIME OF DIAGNOSIS OF PRIMARY SJÖGREN SYNDROME: A HIGHLY-ACTIVE SYSTEMIC SUBSET OF THE DISEASE (2019) (1)
OP0090 THE OCCURRENCE OF SUBCLINICAL AND CLINICAL ATHEROSCLEROSIS IN RHEUMATOID ARTHRITIS, RESULTS FROM THE 3-YEAR, MULTICENTER, PROSPECTIVE, OBSERVATIONAL, GIRRCS STUDY (2019) (1)
Production of f_0(980), f_2(1270) and \phi(1020) in hadronic Z^0 decay (1998) (1)
Budget Impact Analysis of anakinra in the treatment of patients with Still’s Disease (2020) (1)
Multiplicity dependence of Bose-Einstein correlations in hadronic Z0 decays (1996) (1)
γ/δ T Cells are not Involved in the Natural and Antibody-Dependent Cytotoxicity of Peripheral blood Mononuclear Cells in Inflammatory Bowel Disease (1997) (1)
[Immunosuppressive therapy of vasculitis: current aspects and perspectives]. (1996) (1)
Basic (PS01–PS58) (2012) (1)
OP0015 Induction of remission and maintenance in early, aggressive rheumatoid arthritis using adalimumab in combination with methotrexate with or without short-term high-dose glucocorticoids: results of a phase iv multicenter, randomized, double blind study (clintrial.gov: NCT00480272) (2017) (1)
FRI0437 Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from SSC Patients Induces an Anti Angiogenetic Effect, when Co-Cultured with Endothelial Cells (2015) (1)
POS0326 ROLE OF THE IL-25 / IL-17RB AXIS IN TH9 POLARIZATION IN PATIENTS WITH PROGRESSIVE SYSTEMIC SCLEROSIS (2021) (1)
THU0164 Subclinical atherosclerosis and cardiovascular events in italian patients with rheumatoid arthritis: results from multicenter girrcs (gruppo italiano di ricerca in reumatologia clinica e sperimentale) study (2017) (1)
ST 789, A Candidate for Combination Therapies of Infections and Cancer (1992) (1)
FRI0504 Prognostic Factors of Adult Onset Still's Disease: Analysis of 100 Cases in 3 Tertiary Referral Centers (2016) (1)
A measurement of the Bd0 oscillation frequency using leptons and D*± mesons (1996) (1)
Quality of life and unmet needs in patients with inflammatory arthropathies: results from the multicentre, observational RAPSODIA study RHEUMATOLOGY (2015) (1)
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center (2021) (1)
Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry. (2022) (1)
Pathogenesis of the Endothelial Damage and Related Factors (2012) (1)
POS0177 POTENTIAL INVOLVEMENT OF IL-40 AND IL-40-PRODUCING CELLS IN PRIMARY SJOGREN’S SYNDROME (pSS) AND pSS-ASSOCIATED LYMPHOMA (2021) (1)
THU0265 THYMIC STROMAL LYMPHOPOIETIN (TSLP) AS A BIOMARKER OF PRIMARY SJÖGREN’S SYNDROME (PSS) AND RELATED LYMPHOMA: VALIDATION IN INDEPENDENT COHORTS (2020) (1)
A MEASUREMENT OF CHARGED-PARTICLE MULTIPLICITY IN Z(O)-]C(C)OVER-BAR AND Z(O)-]B(B)OVER-BAR EVENTS (1995) (1)
AB1203-HPR Comparison of quality of life of patients with rheumatoid arthritis, psoriatic arthritis and ankilosing spondilitis with treatment or prescription of biologic drugs: results from the cara study (2017) (1)
Big Data International Primary Sjogren Syndrome Registry : Baseline Characterization and Diagnostic Approach in 6047 Patients Fulfilling the 2002 AE Criteria (2015) (1)
SAT0191 Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren’s syndrome (2013) (1)
Measurements of the b quark forward-backward asymmetry around the Z 0 peak using jet charge and vertex charge (1997) (1)
Rare Particle Searches with the high altitude SLIM experiment (2006) (1)
Brain Tuberculoma as a Differential Diagnosis of Single Intracranial Lesion: Case Report (2020) (1)
Search for the B meson in hadronic Z 0 decaysc (1998) (0)
EUROPEAN ORGANISATION FOR NUCLEAR RESEARCH CERN-PPE/96-118 August 14, 1996 Search for Neutral Higgs Bosons in Z Decays Using the OPAL Detector at LEP (1996) (0)
SAT0287 Ethnic Differences Strongly Influence The Phenotypic Expression of Primary Sjögren: Study of 7887 Patients from 20 Countries on 5 Continents (EULAR-SS Task Force Big Data Sjögren Project) (2016) (0)
SAT0262 BCL2-associated athanogene 3 protein is associated with B-cell hyperactivity including lymphoma in primary sjÖgren's syndrome (2017) (0)
THU0277 HOW THE AGE AT DIAGNOSIS MODIFIES THE PHENOTYPE OF PRIMARY SJÖGREN SYNDROME: ANALYSIS IN 11,420 PATIENTS (BIG DATA SJÖGREN PROJECT) (2019) (0)
AB0550 PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJÖGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJÖGREN PROJECT) (2019) (0)
A measurement of the tau(-)-> e(-)(nu)over-bar(e)nu(tau) branching ratio (1996) (0)
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study (2022) (0)
Potential of stem cells in the treatment of rheumatic disease (2014) (0)
THU0284 Predicting survival in 6240 patients with primary sjÖgren' syndrome (big data sjÖgren project) (2017) (0)
AB0919 H-Ferritin and CD68+/H-ferritin+ Cells Are Increased in The Skin of Adult Onset Still's Disease Patients and Correlate with The Disease Activity (2016) (0)
Tests of the Standard Model andConstraints on New Physics fromMeasurements of Fermion-pairProduction at 130 { 172 GeV at LEPThe OPAL (2007) (0)
Effects of Raloxifene (RAL) on proliferation in healthy (H) and rheumatoid arthritis (RA) synoviocytes (2011) (0)
Measurement of F (Z ~ bb)/F (Z ~ hadrons) using leptons (1993) (0)
Search for the standard model Higgs boson in e(+)e(-) collisions at root s=161-172 GeV (1998) (0)
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis (2017) (0)
A measurement of the AZ lifetime (1995) (0)
FRI0230 Tocilizumab in the real clinical practice: a preliminary descriptive analysis from the italian observational trust study (2013) (0)
FRI0006 ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS (2020) (0)
Measurements of the Inclusive Branching Ratios of-Leptons to K 0 S and Charged K ( 892 ) The OPAL Collaboration (1998) (0)
Measurement of triple gauge boson couplings from W + W − production at √ s = 172 GeV The OPAL Collaboration (2008) (0)
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts (2019) (0)
Serum levels of vascular endothelial growth factor (VEGF) according to disease duration (2011) (0)
AB0244 Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC) (2013) (0)
Fibroblast expression of CD248 may contribute to exacerbate microvascular damage during systemic sclerosis. (2022) (0)
SAT0233 Characteristics of primary sjögren’s syndrome (PSS) patients with cryoglobulinemia in a large cohort of patients, and differences between hypergammaglobulinemic and cryoglobulinemic vasculitis in PSS (2013) (0)
Traumatic Buccal and Inferior Alveolar Pseudoaneurysm Associated With Von Willebrand Disease: A Challenging Case Treated by Endovascular Approach (2020) (0)
EXPRESSION OF THE FOUR AND A HALF LIM ONLY PROTEIN FHL2 IN RHEUMATOID ARTHRITIS AND INVOLVEMENT IN MIGRATORY AND INVASIVE BEHAVIOUR IN RASF (2007) (0)
[Leonardo and human flight]. (1952) (0)
SAT0284 Association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary sjÖgren's syndrome (2017) (0)
SAT0313 Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients (2017) (0)
Immunomodulating activity of Famotidine and Nizatidine (1989) (0)
AB0716 FIBROMYALGIA SYNDROME SEVERITY ACCORDING TO AGE CATEGORIES: RESULTS FROM A NATIONAL REGISTER (2021) (0)
T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy. (2020) (0)
Measurement of $$\Gamma (Z^0 \to b\bar b)/\Gamma (Z^0 \to hadrons)$$ using a double tagging method (1994) (0)
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis. (2022) (0)
Evidence of Drug Interaction between Cyclosporin A and H2-receptor Antagonists in Sprangue-Dawley rats (1990) (0)
POS1375 THE EVALUATION OF OBESITY IN ADULT-ONSET STILL’S DISEASE, DATA FROM A LARGE MULTICENTRE COHORT. (2022) (0)
Paracoccidioidomycosis in the Central Nervous System (2020) (0)
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study. (2021) (0)
SAT0219 Prevalence and predictive role of traditional cardiovascular risk factors in a cohort of sjögren’s syndrome patients (2013) (0)
The evidence of microchimerism both lends support to and raises doubts about its specific role in (0)
Measurement of the Tau Lepton Polarization and its Forward-Backward Asymmetry from Z 0 Decays The OPAL Collaboration (1996) (0)
A measurement of the forward-backward asymmetry of e+e−→cc¯ and e+e−→bb¯ at centre of mass energies on and near theZ 0 peak usingD *± mesons (1993) (0)
AB0369 EFFICACY AND SAFETY OF RITUXIMAB ORIGINATOR AND BIOSIMILAR IN PRIMARY SJÖGREN’S SYNDROME IN A REAL-LIFE SETTING (2020) (0)
Upper limit on the nu(tau) mass from tau->3h nu(tau) decays (1996) (0)
Drug interaction with Ciclosporin A (1990) (0)
Measurement of Single Photon Production in e + e � Collisions near the Z 0 Resonance The OPAL Collaboration (1998) (0)
Measurements of the B 0 and L 0 lifetimess b OPAL Collaboration (1998) (0)
Ferritin and Severe COVID-19, from Clinical Observations to Pathogenic Implications and Therapeutic Perspectives. (2020) (0)
SAT0213 Low-Dose Imatinib in the Treatment of Scleroderma Pulmonary Involvement: Results of a Phase II Pilot Study. (2013) (0)
[Renal vasculitis: review of the literature and description of a clinical case]. (1988) (0)
Systematic review on the use of biologics in adult-onset still's disease. (2022) (0)
Fibromyalgia severity according to age categories: results of a cross-sectional study from a large national database. (2021) (0)
Prompt J = production in hadronic Z 0 decays The OPAL Collaboration (1996) (0)
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the “hyperferritinemic syndromes” (2023) (0)
A Study of b Quark Fragmentation into B 0 andB + Mesons at LEPThe OPAL CollaborationAbstractA (2007) (0)
Fibrinolytic pattern of healthy (H) and rheumatoid arthritis (RA) synoviocytes treated with Raloxifene (2011) (0)
Additional Treatment for Digital Ulcers in Patients with Systemic Sclerosis: A Prospective, Open-Label, Multi-Arm Study for the use of Platelet-Rich Plasma-Lipofilling and Ultrasound-Based Treatments (2021) (0)
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey (2022) (0)
AB0630 Cardiac Magnetic Resonance Imaging with Pharmacological Stress Perfusion in Asymptomatic Patients with Systemic Sclerosis (2016) (0)
Towards a Consensus on the Clinical Applications and Interpretations of the Nailfold Capillaroscopy Standards in Clinical Practice (2022) (0)
Determination of event shape distributions b (0)
PIGMENT EPITHELIUM DERIVED FACTOR SECRETED BY SSC FIBROBLASTS INHIBITS ANGIO AND VASCULOGEN- ESIS IN VITRO (2014) (0)
Observation of production in hadronic Z 0 decays The OPAL Collaboration (1995) (0)
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus (2022) (0)
SAT0641 Performance and agreement of different operators and histological techniques for the assessment of germinal centres in minor salivary glands in primary sjÖgren’s syndrome (2018) (0)
promotes TGFβ signaling and fibrosis in systemic sclerosis. (2017) (0)
THU0148 EFFICACY OF IL-1 INHIBITION ON RHEUMATOID ARTHRITIS AND TYPE 2 DIABETES, LONG-TERM FINDINGS FROM TRACK STUDY, A MULTICENTRE, OPEN-LABEL, RANDOMISED CONTROLLED TRIAL (2020) (0)
Cyclosporin A — H2 Receptor Antagonists Drug Interaction in the Sprague-Dawley Rat (1989) (0)
FRI0282 Serological biomarkers of b-cell lymphoproliferative disorders in patients with primary sjögren’s syndrome: retrospective study in a large italian cohort (2013) (0)
Hadron-hadron and hadron-nuclei collisions at high energies (2000) (0)
A Measurement of Charged Particle Multiplicity in Z 0 ! cc and Z 0 ! bb Events The OPAL Collaboration (1995) (0)
Urokinase-type plasminogen activator (u-PA)/u-PA receptor (u-PAR)-dependent chemoinvasion in healthy (H) and rheumatoid arthritis (RA) synoviocytes (2011) (0)
How the different systemic organ involvements are overlapped in patients with primary Sjogren syndrome: analysis using a mathematical model (2018) (0)
Canakinumab as first-line biological therapy in Still’s disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry (2022) (0)
AB0674 CLINICAL AND IMAGING FEATURES IN SPONDYLOARTHRITIS PATIENTS WITH AND WITHOUT HLA-B27 AND HLA-B51 (2020) (0)
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling (2019) (0)
Measurement of {Mathematical expression} using impact parameters and leptons (1994) (0)
THU0192 Myositis in primary sjægren’s syndrome: Data from a multicenter cohort (2013) (0)
FRI0565 PREVALENCE AND SIGNIFICANCE OF ANTIBODIES AGAINST CITRULLINATED ALPHA-ENOLASE (ANTI-CEP1) IN CONNECTIVE TISSUE DISEASES. (2020) (0)
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network (2021) (0)
Epilepsy in systemic lupus erythematosus. (2020) (0)
both SS diagnosis and classification. (2014) (0)
Machine learning approaches as an alternative to traditional statistical methods in cardiovascular risk prediction (2021) (0)
EUROPEAN ORGANISATION FOR NUCLEAR RESEARCHCERN-PPE / 96-zzz 1 st November 1996 Production of Fermion-pair Events ine + e � Collisions at 161 GeVCentre-of-mass EnergyThe (2007) (0)
Gamma-delta T lymphocytes in HIV-infected patients (1992) (0)
FRI0158 CLINICAL AND IMAGING FEATURES OF ARTICULAR MANIFESTATIONS IN PRIMARY SJÖGREN’S SYNDROME: SIMILARITIES AND DIFFERENCES ACCORDING TO THE TIME OF ONSET (2020) (0)
THU0393 IL-17 Producing Pathogenic T Lymphocytes Co-Express CD20 and are Depleted by Rituximab in Primary sjögren's Syndrome: A Novel Target for an Old Weapon (2015) (0)
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort. (2023) (0)
SAT0283 CLINICAL AND SEROLOGICAL FEATURES OF SYSTEMIC SCLEROSIS IN ITALIAN AND EGYPTIAN PATIENTS (2019) (0)
FRI0414 Evaluation of a novel multi-analyte assay for the detection of autoantibodies in the diagnosis of systemic sclerosis (2018) (0)
A measurement of vertical bar V-cb vertical bar using (B)over-bar(0)->D(*+)l(-)(v)over-bar(l) decays (1997) (0)
THU0251 Familial clustering of autoimmune diseases in sjÖgren’s syndrome: an italian case-control study (2001) (0)
Fibrous Dysplasia of the Sphenoid Sinus: a Case Report (2018) (0)
Biomarkers in primary Sjögren’s syndrome (2021) (0)
POS1267 LONG-TERM SURVEY STUDY OF THE IMPACT OF COVID-19 ON SYSTEMIC AUTOIMMUNE DISEASES. LOW DEATH RATE DESPITE THE INCREASED PREVALENCE OF SYMPTOMATIC INFECTION. ROLE OF PRE-EXISTING INTERSTITIAL LUNG DISEASE AND ONGOING TREATMENTS. (2022) (0)
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study (2020) (0)
Cerebellar Dysplastic Gangliocytoma: Case Report (2020) (0)
AB1182 SPECIALIZED PRO-RESOLVING MEDIATORS (SPMS) AND INFLAMMATORY NETWORKS IN PATIENTS AFFECTED BY ADULT ONSET STILL’S DISEASE (AOSD) AND COVID-19 (2022) (0)
POS1337 ADULT-ONSET STILL’S DISEASE WITH ELDERLY ONSET, RESULTS FROM A MULTICENTRE STUDY AND ASSESSMENT OF AGE INFLUENCE ON CLINICAL FEATURES AND DISEASE OUTCOMES. (2022) (0)
OP0081 Aberrant Expression of IL-22RA1 on Hematopoietic Cells as Immunologically Signature of Primary Sjogren’s Syndrome and Sjogren-Associated Non-Hodgkin Lymphomas (2013) (0)
Sjögren Syndrome Disease Activity Index ( ESSDAI ) and the Clinical ESSDAI ( ClinESSDAI (2017) (0)
Measurement of the Q 2 evolution of the photon structure function F γ 2 The OPAL Collaboration (1997) (0)
A Study of Four-Fermion Final States withHigh Multiplicity at LEPThe OPAL (1996) (0)
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?'. (2016) (0)
Novel Therapeutic Strategies in Sjögren’s Syndrome (2016) (0)
Study of the primary cosmic ray composition around 1000 TeV with EAS-TOP and MACRO (1996) (0)
Science,technology and society (2005) (0)
MEASUREMENT OF THE TAU(-)-]H(-)H(+)H(-)NU(TAU) AND TAU(-)-]H(-)H(+)H(-)GREATER-THAN-OR-EQUAL-TO-1-PI(0)NU(TAU), BRANCHING RATIOS (1995) (0)
A Measurement of |V(cb)| using anti-B0 ---> D*+ lepton- anti-lepton-neutrino decays (1996) (0)
Search for a Narrow Resonance in Z 0 Decays into Hadrons and Isolated Photons The OPAL Collaboration (1996) (0)
[Leonardo da Vinci and human flying]. (1952) (0)
How ethnicity modifies systemic activity of primary Sjögren syndrome : analysis of baseline ESSDAI scores in a multi-ethnic international cohort (2018) (0)
Measurement of the Branching Fractions and Forward-Backward Asymmetries of the Z 0 into Light Quarks The OPAL Collaboration (1997) (0)
Upper limit on theντ mass fromτ → 3hντ decays (1996) (0)
Erratum in: Budget Impact Analysis of anakinra in the treatment of patients with Still’s Disease (2020) (0)
EUROPEAN ORGANISATION FOR NUCLEAR RESEARCH CERN{PPE/94{91 15 June 1994 Observation of Exclusive Decays of B Mesons (1998) (0)
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units (2016) (0)
Strange Baryon Production in Hadronic Z 0 Decays OPAL Collaboration (2019) (0)
Prompt J / $ production in hadronic 2 ’ decays OPAL (0)
Search for charged Higgs bosons in e(+)e(-) collisions at root s = 130-172 GeV (1998) (0)
DETERMINATION OF EVENT SHAPE DISTRIBUTION AND ALPHA(B)(S) FROM Z(0)-]B(B)OVER-BAR EVENTS AT LEP (1995) (0)
Investigation of the String E ect using Final State Photons The OPAL Collaboration (1995) (0)
PO-1145 IORT for Brain Metastases: Final First-Stage Results of a Single-Arm, Open-Label, Phase 2 Trial (2022) (0)
SAT0739-HPR Patients' preferences toward characteristics of treatment with biological agents differ according to experience with their rheumatic disease and treatment received or prescribed: results from the cara study (2017) (0)
A3.1 Pathogenic role of IL-17 producing double negative (DN) T cells in primary sjögren’s syndrome (2014) (0)
A Measurement of the B 0s Lifetime using Reconstructed D − s Mesons The OPAL Collaboration (2014) (0)
Autoimmune screening before adenovirus vector-based DNA vaccine in women may avoid underuse for all the subjects (2021) (0)
OP0044 Antibodies anti-saccharomyces cerevisiae in primary sjÖgren's syndrome: prevalence, clinical associations and possible cross-reactivity with disease specific autoantigens (2017) (0)
FRI0014 Low-dose aspirin may have a role as primary prophylaxis of cardiovascular events in rheumatoid arthritis: evidence from an italian multicentric retrospective study (2018) (0)
SAT0683 A north-south worldwide gradient in systemic activity of primary sjÖgren syndrome: increased severe disease in patients from southern countries (2018) (0)
The measurement of fibromyalgia severity: converting scores between the FIQR, the PSD and the FASmod. (2022) (0)
Chapter 40 Post-COVID-19 syndrome and fibromyalgia (2023) (0)
Measurement of the average b-baryon lifetime and the product branching ratio {Mathematical expression} (1995) (0)
Experimental Hepatotoxicity indiced by Cyclosporin (1988) (0)
SAT0377 Interferon Gamma-Inducible Protein 16 (IFI16) in Primary SjÖgren's Syndrome: A Novel Player in Disease Pathogenesis? (2015) (0)
Measurement of the branching fraction of the radiative decay tau(-)->mu(-)(nu)over-bar(mu)nu(tau)gamma (1996) (0)
Rheumatoid arthritis - aetiopathogenesis and animal models 87. Do We Need to Redefine Seropositivity in RA? (2011) (0)
Measurements of ~ mixing, F(Z ~ ;bb)/F(Z ~ ,hadrons) and semileptonic branching ratios for b-flavoured hadrons in hadronic Z ~ decays (1993) (0)
A study of charm hadron production in Z(0)->c(c)over-bar and Z(0)->b(b)over-bar decays at LEP (1996) (0)
Inhibiting inflammatory cytokines in adult onset Still’s disease. Current trends and new therapeutic perspectives (2019) (0)
OP0310 GENDER AND FIBROMYALGIA SEVERITY: REAL LIFE DATA FROM THE ITALIAN REGISTRY (2021) (0)
EUROPEAN ORGANISATION FOR NUCLEAR RESEARCH CERN-PPE/95-13 3 February 1995 Comparisons of the Properties of Final State Photons in Hadronic Z Decays with Predictions from Matrix Element Calculations (1995) (0)
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis (2023) (0)
Differential expression of SDF-1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implication (2006) (0)
Patrick-FABER test in detecting active sacroiliitis in spondyloarthritis patients: a prospective study using magnetic resonance as reference standard. (2021) (0)
A Measurement of the Forward-BackwardAsymmetry of e + e � ! bbby Applying a Jet Charge Algorithmto Lifetime Tagged EventsThe (2007) (0)
Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: a case series from three European centres. (2022) (0)
COMPUTING AT FUTURE ACCELERATOR AND NON ACCELERATOR LARGE EXPERIMENTS (2002) (0)
THU0352 Worldwide Heterogeneous Diagnostic Approach To Primary Sjögren Syndrome in 8315 Patients (EULAR-SS Task Force Big Data Sjögren Project) (2016) (0)
AB0261 CARDIOMETABOLIC COMORBIDITIES MAY IDENTIFY A MORE SEVERE SUBSET OF RHEUMATOID ARTHRITIS, RESULTS FROM A “REAL-LIFE” STUDY (2022) (0)
A First measurement of the Lambda anti-Lambda and Lambda Lambda (anti-Lambda anti-Lambda) spin compositions in hadronic Z0 decays (1996) (0)
Patients’ Preferences Toward Characteristics of Treatment with Biological Agents Differ According to Experience with their Rheumatic Disease and Treatment Received or Prescribed: Results from the Cara Study (2016) (0)
[Antimyocardial autoimmunity in ischemic coronary disease]. (1987) (0)
An improved measurement of the Bf lifetime (2003) (0)
Correction to: Impact of smoking habit on adult-onset Still’s disease prognosis, findings from a multicentre observational study (2022) (0)
Urokinase-type plasminogen activator u-PA/u-PA receptor-dependent proliferation in healthy (H) and rheumatoid arthritis (RA) synoviocytes (2011) (0)
Effect of Nizatidine on Cyclosporin A blood levels in the rat: preliminary results of an experimental study (1989) (0)
Morphological study on the interaction between enterococci and human spermatozoa (1987) (0)
THU0231 IL-17 polarization of mait cells derive from the activation of two different pathways (2017) (0)
EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH CERN-PPE/95-02 11th January 1995 A Study of Charm Meson Production in Semileptonic (1995) (0)
SAT0457 SjÖgren big data project, the first example of data sharing in autoimmune diseases: analysis of 10475 worldwide patients (2018) (0)
First Measurements of Indoor and Outdoor Radon Concentrations in Oujda, Morocco (2001) (0)
Search for possible solar neutrino radiative decays during total solar eclipses (2006) (0)
Determining the PASS cut-off points for the FIQR, FASmod and PSD in patients with fibromyalgia: a registry-based study. (2022) (0)
Comparing Preferences Of Patients With Rheumatic Diseases, Of Experienced Rheumatologists, Nurses And Pharmacists Toward The Treatment Of Rheumatic Diseases With Biological Agents: Results From The Cara Study (2016) (0)
SAT0456 The incidence of cardiovascular events in italian patients with systemic lupus erythematosus is lower than in north european and american cohorts: implication of disease–associated and traditional risk factors as emerged by a 16-year retrospective girrcs study (2018) (0)
Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren’s syndrome (2023) (0)
The Journal of Rheumatology Development of Fibrosis Activated ADAM 12 and Are Involved in Myofibroblast Transdifferentiation and Perivascular Cells in Diffuse Cutaneous Systemic Sclerosis (2016) (0)
A measurement of F (Z ~ bb)/F (Z hadrons) an impact parameter technique using (1993) (0)
SLE, Sjögren’s and APS – treatment (2020) (0)
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome (2017) (0)
A model independent measurement of quark and gluon jet properties and di erences The OPAL Collaboration (1995) (0)
QCD studies with e+e− annihilation data at 130 and 136 GeV (1996) (0)
Measurement of the branching fraction of the radiative decay $\tau^- \rightarrow \mu^- \overline\nu_{\mu}\nu_{\tau}\gamma$ (1996) (0)
Determination of event shape distributions and b s from Z 0 ! b b events at LEP The OPAL Collaboration (1998) (0)
EUROPEAN LABORATORY FOR PARTICLE PHYSICS CERN-EP / 98-039 6 th March 1998 Search for Stable and Long-Lived Massive Charged Particles in e + e − Collisions at √ s = 130 − 183 GeV (1998) (0)
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still’s disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles (2023) (0)
AB0226 Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC) (2013) (0)
Prevalence and characteristics of diffuse idiopathic skeletal hyperostosis (DISH) in Italy (2022) (0)
Jacques Derrida and Deconstruction: a Counterfeit Saussure and a Fanciful Plato (2011) (0)
THU0073 THE ANTI-ANGIOGENIC ROLE OF TOFACITINIB DURING EXPERIMENTAL MODEL OF ARTHRITIS. (2020) (0)
Upper limit on the tau-neutrino mass from tau --> 3 h tau-neutrino decays (1996) (0)
The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease. (2022) (0)
Clinical and immunological disease patterns of primary Sjogren syndrome driven by gender and age at diagnosis (2018) (0)
SAT0290 A Higher Disease Activity in Anti-Ssa/ssb Positive Sjögren's Syndrome Is Explained by A Higher Clinical and Biological B-Cell Activation (2016) (0)
THU0582 Prognostic Factors of Macrophage Activation Syndrome in Adults: Analysis of 40 Cases in 2 Tertiary Referral Centers (2016) (0)
Ciclosporin (CyA) and H2-Receptor Antagonists (1988) (0)
A determination of (Mzo) at LEP using resummed (1993) (0)
OP0044 CYTOKINE PROFILE, HYPERFERRITINEMIA, AND MULTI-VISCERAL INVOLVEMENT CHARACTERISE MACROPHAGE ACTIVATION SYNDROME COMPLICATING ADULT ONSET STILL’S DISEASE. RESULTS FROM A MULTIDIMENSIONAL EVALUATION (2022) (0)
Correspondence on ‘Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis’ (2021) (0)
Search for charged Higgs bosons in e + e − collisions at √ s = 130 − 172 GeV The OPAL Collaboration (2018) (0)
[Cyclosporin (CyA) and H2 antagonists]. (1990) (0)
SAT0025 MIR 106A, MIR 19A-B, MIR 20A and MIR21A regulate vγ9vδ2 functions participating in the inflammatory responses occurring in rheumatoid arthritis (2017) (0)
AB0467 EFFECTIVENESS OF GOLIMUMAB AFTER TNF-INHIBITOR FAILURE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, OR AXIAL SPONDYLOARTHRITIS: RESULTS AT 3 MONTHS FROM THE GO-BEYOND ITALY STUDY (2021) (0)
SAT0302 Analysis of 9302 patients from the big data international primary sjÖgren syndrome cohort: clinical presentation at diagnosis of european vs non-european patients (2017) (0)
A3.8 Association between clinical, histopathological and molecular features in primary Sjögren’s Syndrome: a retrospective study (2014) (0)
Measurement of the Photon Structure Function F γ 2 at Low x The OPAL Collaboration (2018) (0)
SAT0374 IL-36A Axis is Modulated in Patients with Primary Sjogren's Syndrome and Implicated in the Regulation of Gamma-Delta T Cells Immune Functions (2015) (0)
Measurement of the Semileptonic Branching Fraction of Inclusive b Baryon Decays to (cid:3) (1996) (0)
Systemic sclerosis and primary biliary cholangitis share an antibody population with identical specificity. (2023) (0)
Endothelial progenitor cells (epc) characterization in systemic sclerosis (ssc) patients (2006) (0)
The CD248 Expression on Myofibroblast Cells May Contribute to Exacerbate the Microvascular Damage During Systemic Sclerosis (2020) (0)
PS3:48 The incidence of cardiovascular events in italian patients with systemic lupus erythematosus is lower than in north european and american cohorts: implication of disease–associated and traditional ris (2018) (0)
[The expansion of NK CD56+ cells with reduced cytotoxicity in a female patient with systemic sclerosis]. (1992) (0)
MEASUREMENT OF GAMMA(Z(0)-]B(B)OVER-BAR)/GAMMA(Z(0)-]HADRONS) USING A DOUBLE TAGGING METHOD (1995) (0)
Clinical and Immunological Characterization at Diagnosis of 5041 Patients with Primary Sjogren Syndrome Fulfilling the 2002 AE Classification Criteria: The Big Data International Sjogren Project (2015) (0)
Spin alignment of leading K*(892)degrees mesons in hadronic Z degrees decays (1997) (0)
Connecting LuaTEX to MongoDB (2018) (0)
Search for CP Violation in Z 0 � ! + � and an Upper Limit on the Weak Dipole Moment of the Lepton The OPAL Collaboration (1997) (0)
Biotech on the Rise: The Treatment of Psoriasis with Biological Drugs (2012) (0)
Urokinase-type plasminogen activator (u-PA) activity in healthy (H) and rheumatoid arthritis (RA) synoviocytes treated with Raloxifene (RAL) (2011) (0)
1 Pathogenesis of the Endothelial Damage and Related Factors (2012) (0)
SAT0395 Factors Influencing Patient-Reported Indexes in Primary SjÖgren's Syndrome: A Multicenter Experience (2015) (0)
Upper l imit on the mass from 7-> 3 hr , decays (2019) (0)
Typesetting and highlighting Unicode source code with LATEX: a package comparison (2014) (0)
Hyperon Production in Hadronic Z 0 Decays The OPAL Collaboration (1996) (0)
Characterization of Baseline Systemic Activity Using the New ClinESSDAI in the Big Data Sjogren Project Cohort: Analysis in 3316 Patients (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Roberto Giacomelli?

Roberto Giacomelli is affiliated with the following schools:

Roberto Giacomelli's Academic­Influence.com Rankings

Roberto Giacomelli's Degrees

Similar Degrees You Can Earn

Why Is Roberto Giacomelli Influential?

Roberto Giacomelli's Published Works

Published Works

What Schools Are Affiliated With Roberto Giacomelli?

Roberto Giacomelli's AcademicInfluence.com Rankings